Results 211 to 220 of about 92,785 (261)
Some of the next articles are maybe not open access.
Advances in Anatomic Pathology, 1994
On: CD31: An Immunospecific Marker for Endothelial Differentiation in Human Neoplasms.
Commentary by Teri A. Longacre +1 more
openaire +1 more source
On: CD31: An Immunospecific Marker for Endothelial Differentiation in Human Neoplasms.
Commentary by Teri A. Longacre +1 more
openaire +1 more source
Significance of p53 and CD31 in astrogliomas
Medical Oncology, 2008Astrogliomas are the most common primary brain tumor. Its progression is the result of activation of oncogenes, inactivation of tumor suppressor genes (TSGs), and expression of various growth factors. The angiogenesis and p53 in astrogliomas play an important role in its grading, treatment strategies, and hence its clinical outcome.To analyze the ...
Abdul-Zaher M, Khattab +3 more
openaire +2 more sources
PECAM‐1/CD31 in Infarction and Longevity
Annals of the New York Academy of Sciences, 2007Abstract: Inflammation has recently proven to be associated with the pathogenesis of atherosclerosis and inflammatory genes are good candidates for the risk of developing atherosclerosis. The early phase of atherosclerosis involves the recruitment of inflammatory cells from the circulation and their transendothelial migration.
LISTI', Florinda +8 more
openaire +3 more sources
Life after the thymus: CD31+ and CD31− human naive CD4+ T-cell subsets
Blood, 2009AbstractEarly in life, thymic export establishes the size and the diversity of the human naive T-cell pool. Yet, on puberty thymic activity drastically decreases. Because the overall size of the naive T-cell pool decreases only marginally during ageing, peripheral postthymic expansion of naive T cells has been postulated to account partly for the ...
Siegfried, Kohler, Andreas, Thiel
openaire +2 more sources
2011
Summary. The data about expression of endothelial cells CD31 marker in SOFT Tissues malignant fibrotic histiocytoma (pleomorphic variant) in 41 patient are analysed. The patients enrolled in this study were treated at A.T. Abbasova City oncologic dispensary (Baku) and Oncologic Clinic of Azerbaijan Medical University for period from 2000 to 2009 ...
openaire +3 more sources
Summary. The data about expression of endothelial cells CD31 marker in SOFT Tissues malignant fibrotic histiocytoma (pleomorphic variant) in 41 patient are analysed. The patients enrolled in this study were treated at A.T. Abbasova City oncologic dispensary (Baku) and Oncologic Clinic of Azerbaijan Medical University for period from 2000 to 2009 ...
openaire +3 more sources
CD31 expression in plasmacytic/plasmablastic lesions
Annals of Diagnostic Pathology, 2013Although CD31 has been considered one of the better, if not the best, immunohistochemical marker of endothelial cells and thereby vascular neoplasia, it is not unequivocally specific to this group of tumors. We examined CD31 staining in 34 plasmacytic lesions including 15 plasma cell myelomas, 1 extraosseous plasmacytoma, 10 plasmablastic variants of ...
Elizabeth, Plocharczyk, Paul E, Wakely
openaire +2 more sources
CD31 Expression in Intratumoral Macrophages
The American Journal of Surgical Pathology, 2001CD31 (platelet endothelial adhesion molecule, PECAM-1) is generally regarded to be the most sensitive and specific endothelial marker in paraffin sections. We have recently encountered several cases in which intratumoral CD31-positive macrophages were misinterpreted as evidence of a vascular sarcoma.
J K, McKenney, S W, Weiss, A L, Folpe
openaire +2 more sources
The Effect of CD31 on Coronary Collateral Development
Cardiovascular & Hematological Agents in Medicinal ChemistryBackground: Coronary collaterals are the feeding bridges between the main epicardial arteries, and research has shown that this collateral development plays a crucial role in myocardial performance, especially in patients with coronary artery disease. However, the evolution of these collaterals has not been fully explained. Objective: In this study,
Huseyin Akcali +8 more
openaire +2 more sources